Controlled trial comparing prednisolone with an elemental diet plus non-absorbable antibiotics in active Crohn's disease.

S Saverymuttu, H J Hodgson, V S Chadwick

In a randomised clinical trial, patients with moderately active Crohn's disease received either prednisolone 0.5 mg/kg/day plus a normal diet, or an elemental diet plus oral framycetin, colistin and nystatin. Patients were assessed using the Crohn's disease activity index (CDAI), ESR, and faecal granulocyte excretion quantified by 111In-autologous leucocytes. Five patients were intolerant of the elemental diet plus antibiotics and were withdrawn from the trial within 72 hours. Sixteen patients completed 10 days treatment on each regime. Fifteen of 16 patients on elemental diet plus antibiotics and all 16 patients on prednisolone improved with marked, but statistically indistinguishable falls in CDAI, ESR, and faecal granulocyte excretion between the two groups. Thus a regime decreasing the intraluminal concentration of bacteria and complex food molecules, was associated with rapid improvement in activity of Crohn's disease. This suggests that these intraluminal factors play a role in maintaining inflammation and that their removal or alteration offers an approach to management.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Issa, M., Binion, D. G. (2008). Bowel Rest and Nutrition Therapy in the Management of Active Crohn's Disease. Nutr Clin Pract 23: 299-308 [Abstract] [Full Text]  
• Wiese, D. M., Rivera, R., Seidner, D. L. (2008). Is There a Role for Bowel Rest in Nutrition Management of Crohn's Disease?. Nutr Clin Pract 23: 309-317 [Abstract] [Full Text]  
• Jeejeebhoy, K. N. (2002). Clinical nutrition: 6. Management of nutritional problems of patients with Crohn's disease. CMAJ 166: 913-918 [Full Text]  
• Leiper, K, Woolner, J, Mullan, M M C, Parker, T, van der Vliet, M, Fear, S, Rhodes, J M, Hunter, J O (2001). A randomised controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn's disease. Gut 49: 790-794 [Abstract] [Full Text]  
• Andoh, A., Takaya, H., Araki, Y., Tsujikawa, T., Fujiyama, Y., Bamba, T. (2000). Medium- and Long-Chain Fatty Acids Differentially Modulate Interleukin-8 Secretion in Human Fetal Intestinal Epithelial Cells. J. Nutr. 130: 2636-2640 [Abstract] [Full Text]  
• Kennedy, R.J., Kirk, S.J., Gardiner, K.R. (2000). Promotion of a Favorable Gut Flora in Inflammatory Bowel Disease. JPEN J Parenter Enteral Nutr 24: 189-195 [Abstract]  
• Souba, W. W. (1997). Nutritional Support. NEJM 336: 41-48 [Full Text]  
• Fernandez-Banares, F., Cabre, E., Esteve-Comas, M., Gassull, M. A. (1995). How Effective Is Enteral Nutrition in Inducing Clinical Remission in Active Crohn's Disease? A Meta-Analysis of the Randomized Clinical Trials. JPEN J Parenter Enteral Nutr 19: 356-364 [Abstract]  
• Teahon, K., Pearson, M., Levi, A. J., Bjarnason, I. (1995). Practical Aspects of Enteral Nutrition in the Management of Crohn's Disease. JPEN J Parenter Enteral Nutr 19: 365-368 [Abstract]  
• Board, A.S.P.E.N. (1993). Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients. JPEN J Parenter Enteral Nutr 17: 1SA-52SA  
• Sitrin, M. D. (1992). Invented Review: Nutrition Support in Inflammatory Bowel Disease. Nutr Clin Pract 7: 53-60 [Abstract]  
• Koretz, R. L. (1990). Invited Review: Predigested Diets: Should We Mash the Meat When We Mash the Potatoes?. Nutr Clin Pract 5: 241-246  
• Afdhal, N.H., Kelly, J., Mccormick, P.A., O'Donoghue, D.P. (1989). Remission Induction in Refractory Crohns Disease Using a High Calorie Whole Diet. JPEN J Parenter Enteral Nutr 13: 362-365 [Abstract]